Literature DB >> 22358662

Carbohydrate and amino acid metabolism during batch culture of a human lymphoblastoid cell line, BTSN6.

C P Marquis1, J P Barford, C Harbour, A Fletcher.   

Abstract

This work presents data on the carbohydrate and amino acid metabolism of a lymphoblastoid cell line producing an IgG1 antibody. In static culture, it was observed that lactate levels were significantly lowered when the cells were cultured on galactose as a carbon source. The use of carbohydrate substitution may be useful in lowering lactate levels, if it is established that this component is toxic to the cells. In addition, carbohydrate substitution may be used to modify glycosylation patterns and hence pharmacokinetic properties of glycoproteins.The amino acids glutamine and tryptophan were shown to be limiting in batch culture on this medium (DR, a 1:1 mixture of DMEM and RPMI, with 4mM glutamine). Amino acids produced included alanine, proline and glutamate. Serine was consumed to exhaustion, which was followed by a depletion of extracellular glycine. Amino acid metabolism, specific antibody productivity and specific growth rate were shown to be functions of the inoculation density in stirred flask culture. The results have implications for the design of media for both low and high density antibody manufacture by these cell lines.

Entities:  

Year:  1996        PMID: 22358662     DOI: 10.1007/BF02215662

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  19 in total

1.  Nutrition needs of mammalian cells in tissue culture.

Authors:  H EAGLE
Journal:  Science       Date:  1955-09-16       Impact factor: 47.728

2.  Glutamine and glucose metabolism in human peripheral lymphocytes.

Authors:  M S Ardawi
Journal:  Metabolism       Date:  1988-01       Impact factor: 8.694

3.  Glucose-dependent glycosylation of secretory glycoprotein in mouse myeloma cells.

Authors:  N J Stark; E C Heath
Journal:  Arch Biochem Biophys       Date:  1979-02       Impact factor: 4.013

4.  Role of environmental conditions on the expression levels, glycoform pattern and levels of sialyltransferase for hFSH produced by recombinant CHO cells.

Authors:  W Chotigeat; Y Watanapokasin; S Mahler; P P Gray
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

5.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.

Authors:  L J Reitzer; B M Wice; D Kennell
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

6.  The cultivation of animal cells at controlled dissolved oxygen partial pressure. Reprinted from Biotechnology and Bioengineering Vol. X, Issue 6, Pages 801-814 (1968).

Authors:  D G Kilburn; F C Webb
Journal:  Biotechnol Bioeng       Date:  2000-03-20       Impact factor: 4.530

7.  Effects of dissolved oxygen concentration on hybridoma growth and metabolism in continuous culture.

Authors:  W M Miller; C R Wilke; H W Blanch
Journal:  J Cell Physiol       Date:  1987-09       Impact factor: 6.384

8.  Reciprocal regulation of glucose and glutamine utilization by cultured human diploid fibroblasts.

Authors:  H R Zielke; P T Ozand; J T Tildon; D A Sevdalian; M Cornblath
Journal:  J Cell Physiol       Date:  1978-04       Impact factor: 6.384

9.  Balanced nutrient fortification enables high-density hybridoma cell culture in batch culture.

Authors:  E C Jo; H J Park; J M Park; K H Kim
Journal:  Biotechnol Bioeng       Date:  1990-10-05       Impact factor: 4.530

10.  Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells.

Authors:  M Board; S Humm; E A Newsholme
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

View more
  1 in total

1.  The role of vitamins and amino acids on hybridoma growth and monoclonal antibody production.

Authors:  P Ducommun; P A Ruffieux; U von Stockar; I Marison
Journal:  Cytotechnology       Date:  2001-10       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.